Terms: = Colorectal cancer AND Ki-67 AND Treatment
264 results:
1. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated cancer (CAC).
Sun A; Ge J; Ding K; Gao Z; Zhang Y
Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
[TBL] [Abstract] [Full Text] [Related]
2. New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses.
Karaca C; Demir Karaman E; Leblebici A; Kurter H; Ellidokuz H; Koc A; Ellidokuz EB; Isik Z; Basbinar Y
Sci Rep; 2024 Apr; 14(1):8762. PubMed ID: 38627442
[TBL] [Abstract] [Full Text] [Related]
3. Desulfovibrio desulfuricans and its derived metabolites confer resistance to FOLFOX through METTL3.
Li G; Liu H; Yu Y; Wang Q; Yang C; Yan Y; Wang F; Mao Y
EBioMedicine; 2024 Apr; 102():105041. PubMed ID: 38484555
[TBL] [Abstract] [Full Text] [Related]
4. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.
Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
[TBL] [Abstract] [Full Text] [Related]
5. Ochratoxin A promotes chronic enteritis and early colorectal cancer progression by targeting Rinck signaling.
Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
Phytomedicine; 2024 Jan; 122():155095. PubMed ID: 37844381
[TBL] [Abstract] [Full Text] [Related]
6. Fisetin induces the upregulation of AKAP12 mRNA and anti-angiogenesis in a patient-derived organoid xenograft model.
Kim N; Kwon J; Shin US; Jung J
Biomed Pharmacother; 2023 Nov; 167():115613. PubMed ID: 37801904
[TBL] [Abstract] [Full Text] [Related]
7. Crocin exerts anti-tumor effect in colon cancer cells via repressing the JAK pathway.
Yang H; Zhang Y; Zhang D; Qian L; Yang T; Wu X
Eur J Histochem; 2023 Sep; 67(3):. PubMed ID: 37700733
[TBL] [Abstract] [Full Text] [Related]
8. Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer.
Pantalone MR; Martin Almazan N; Lattanzio R; Taher C; De Fabritiis S; Valentinuzzi S; Bishehsari F; Mahdavinia M; Verginelli F; Rahbar A; Mariani-Costantini R; Söderberg-Naucler C
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37654195
[TBL] [Abstract] [Full Text] [Related]
9. Calcium-Sensing Receptor Expression in Breast cancer.
Busic-Pavlek I; Dumic-Cule I; Kovacevic L; Milosevic M; Delimar P; Korsa L; Marusic Z; Prutki M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511437
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological Value Of Epidermal Growth Factor Receptor (EGFR) And ki-67 Expression In colorectal Adenoma And Adenocarcinoma.
Ahmed Nor EM; Saied EM; Mina SN; Shareef MM; Abdelaziz DM
J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S124-S130. PubMed ID: 37482844
[TBL] [Abstract] [Full Text] [Related]
11. Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy.
Wang K; Fu S; Dong L; Zhang D; Wang M; Wu X; Shen E; Luo L; Li C; Nice EC; Huang C; Zou B
Autophagy; 2023 Dec; 19(12):3132-3150. PubMed ID: 37471054
[TBL] [Abstract] [Full Text] [Related]
12. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract] [Full Text] [Related]
13. Leptin and leptin receptor expression as biomarkers for breast cancer: a retrospective study.
Wang Y; Du L; Jing J; Zhao X; Wang X; Hou S
BMC Cancer; 2023 Mar; 23(1):260. PubMed ID: 36941557
[TBL] [Abstract] [Full Text] [Related]
14. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis.
Centonze G; Maisonneuve P; Prinzi N; Pusceddu S; Albarello L; Pisa E; Barberis M; Vanoli A; Spaggiari P; Bossi P; Cattaneo L; Sabella G; Solcia E; La Rosa S; Grillo F; Tagliabue G; Scarpa A; Papotti M; Volante M; Mangogna A; Del Gobbo A; Ferrero S; Rolli L; Roca E; Bercich L; Benvenuti M; Messerini L; Inzani F; Pruneri G; Busico A; Perrone F; Tamborini E; Pellegrinelli A; Kankava K; Berruti A; Pastorino U; Fazio N; Sessa F; Capella C; Rindi G; Milione M
Neuroendocrinology; 2023; 113(4):457-469. PubMed ID: 36417840
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of the Anti-cancer Potential of
Darwish H; Alharthi S; Mehanna RA; Ibrahim SS; Fawzy MA; Alotaibi SS; Albogami SM; Albogami B; Hassan SHA; Noureldeen A
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234779
[TBL] [Abstract] [Full Text] [Related]
17. An innovative diagnosis in gastrointestinal neuroendocrine neoplasms using Wax-Physisorption-Kinetics-based FTIR Imaging.
Chen YT; Huang PY; Wang JY; Lee YC; Chai CY
Sci Rep; 2022 Oct; 12(1):17168. PubMed ID: 36229592
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Spectrum and Endoscopic treatment of Gastrointestinal Carcinoid Tumour.
Xue L; Cai Y; Chen W; Chen S; Xue P
J Coll Physicians Surg Pak; 2022 Oct; 32(10):1330-1333. PubMed ID: 36205280
[TBL] [Abstract] [Full Text] [Related]
19. The treatment efficacy of three-layered functional polymer materials as drug carrier for orthotopic colon cancer.
Liu Z; Wang D; Cao Q; Li J
Drug Deliv; 2022 Dec; 29(1):2971-2983. PubMed ID: 36101475
[TBL] [Abstract] [Full Text] [Related]
20. Effect of exercise on tumor markers - Is exercise anti-tumorigenic in humans?: A scoping review of preliminary clinical investigations.
Kang DW; Barnes O; Vander Heiden MG; Dieli-Conwright CM
Crit Rev Oncol Hematol; 2022 Oct; 178():103779. PubMed ID: 35940512
[TBL] [Abstract] [Full Text] [Related]
[Next]
